IART

Integra LifeSciences Holdings Corporation
$13.21
-0.32 (-2.37%)
Mkt Cap 1.03B
Volume 830,981
52W Range 8.7-20.49
Sector Healthcare
Beta 1.21
EPS (TTM) -0.09 USD
P/E Ratio -1.85
Revenue (TTM) 1.65B USD
Rev Growth (5Y) +3.6%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$14.64
Fair Value weak signal
9.8% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 1.64B 1.61B 1.54B 1.56B 1.54B 1.37B 1.52B 1.47B 1.19B 992.08M 882.73M 928.30M
Net Income (516.47M) (6.94M) 67.74M 180.55M 169.07M 133.89M 50.20M 60.80M 64.74M 74.56M (3.52M) 34.00M
EPS -6.73 -0.09 0.87 2.18 2.00 1.58 0.59 0.73 0.83 1.00 -0.05 0.52
Free Cash Flow (45.25M) 24.96M 73.09M 217.38M 264.35M 139.94M 96.90M 121.94M 71.04M 69.08M 61.07M 37.07M
FCF / Share -0.59 0.32 0.94 2.62 3.12 1.65 1.13 1.47 0.91 0.92 0.83 0.57
Operating CF 50.38M 129.38M 139.96M 264.47M 312.43M 203.83M 231.43M 199.68M 114.54M 116.41M 94.48M 79.46M
Total Assets 3.60B 4.04B 3.78B 3.89B 3.78B 3.62B 3.30B 3.11B 3.21B 1.81B 1.77B 1.58B
Total Debt 2.03B 1.98B 1.68B 1.63B 1.67B 1.66B 1.46B 1.35B 1.84B 665.00M 714.97M 630.00M
Cash & Equiv 235.05M 246.38M 276.40M 456.66M 513.45M 470.17M 198.91M 138.84M 174.94M 102.06M 48.13M 71.99M
Book Value 1.04B 1.55B 1.59B 1.80B 1.68B 1.51B 1.42B 1.38B 962.31M 839.67M 751.44M 704.32M
Return on Equity -0.49 -0.00 0.04 0.10 0.10 0.09 0.04 0.04 0.07 0.09 -0.00 0.05
IART News
Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting
Oct 16, 2026 04:39 AM · globenewswire.com
INTEGRA LIFESCIENCES HOLDINGS CORPORATION IART INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 21.2% Share Drop
Oct 13, 2026 02:51 PM · businesswire.com
Integra LifeSciences (NASDAQ:IART) & Precision Optics (NASDAQ:POCI) Critical Review
Oct 11, 2026 10:15 PM · defenseworld.net
Integra LifeSciences (NASDAQ: IART) prices $450 million notes to refinance debt
Oct 11, 2026 10:02 PM · defenseworld.net
A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% Gain -- GF Value $20.47 vs Price $13.41
Oct 08, 2026 04:15 PM · gurufocus.com
INTEGRA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corporation on Behalf of Integra Stockholders and Encourages Investors to Contact the Firm
Oct 06, 2026 01:30 PM · globenewswire.com
Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026
Oct 06, 2026 04:30 AM · globenewswire.com
INTEGRA LIFESCIENCES HOLDINGS CORPORATION INVESTIGATION: IART Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
Oct 05, 2026 03:20 PM · globenewswire.com
Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction
Oct 05, 2026 11:00 AM · gurufocus.com
Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction
Oct 05, 2026 10:28 AM · prnewswire.com